読んでおきたい麻酔科学論文

出版社： 克誠堂出版
著者：
発行日： 2022-02-01
分野： 臨床医学：外科  >  麻酔科学/ペイン
ISBN： 9784771905559
電子書籍版： 2022-02-01 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,940 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,940 円(税込)

購入する

商品紹介

編者が綺羅星の如くある論文から（citation indexの高いものを選択し、類似テーマを整理し）62編を選出し、各分野の一人者が解説。温故知新

目次

  • 第1章　麻酔の安全
    第2章　静脈麻酔薬
    第3章　オピオイドとオピオイドアンタゴニスト
    第4章　痛み、鎮痛法
    第5章　吸入麻酔薬
    第6章　局所麻酔薬
    第7章　筋弛緩薬と筋弛緩薬モニタリング
    第8章　小児麻酔
    第9章　産科麻酔
    第10章　脳神経外科麻酔・脳保護
    第11章　心臓麻酔、心保護、心合併症
    第12章　モニタリング
    第13章　輸血
    第14章　体温・悪性高熱症
    第15章　気道管理
    第16章　一酸化窒素
    第17章　ICU　呼吸管理
    第18章　術後管理・合併症

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 麻酔の安全

P.5 掲載の参考文献
1) Institute of Medicine(US)Committee on Quality of Health Care in America. In:Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human:building a safer health system. Washington(DC):National Academies Press(US);2000.
 
2) Cherney FW, Posner KL, Caplan RA. Adverse respiratory events infrequently leading to malpractice suits. A closed claims analysis. Anesthesiology 1991;75:832-9.
 
3) Liau A, Havidich JE, Onega T, et al. The national anesthesia clinical outcomes registry. Anesth Analg 2015;121:1604-10.
PubMed
4) Dutton RP, Dukatz A. Quality improvement using automated data sources:the anesthesia quality institute. Anesthesiol Clin 2011;29:439-54.
PubMed
5) Ali HH. A new device for monitoring force of thumb adduction. Br J Anaesth 1970;42:83-5.
PubMed
P.9 掲載の参考文献
1) Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery based on a study of 599,548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954;140:2-34.
PubMed
2) Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941;2:281-4.
 
3) Tremper KK. Anesthesiology:from patient safety to population outcomes:the 49th annual Rovenstine lecture. Anesthesiology 2011;114:755-70.
PubMed
P.13 掲載の参考文献
1) Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961;178:261-6.
PubMed
2) Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery based on a study of 599,548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954;140:2-34.
PubMed
P.17 掲載の参考文献
1) 日本光電工業株式会社ホームページ. 青柳卓雄氏とパルスオキシメータ. https://www.nihonkohden.co.jp/information/aoyagi/(accessed Aug, 2021)
 
2) Gaba DM, Maxwell M, DeAnda A. Anesthetic mishaps:breaking the chain of accident evolution. Anesthesiology 1987;66:670-6.
PubMed
P.21 掲載の参考文献
1) 奥田泰久. 判例ピックアップ(第18回)硬膜外麻酔後脊髄硬膜外血腫 きわめてまれな合併症だが, 重篤な結果となった場合は医療訴訟に至る可能性がある. LiSA 2017;24:1088-96.
 
2) 日本ペインクリニック学会, 日本麻酔科学会, 日本区域麻酔学会合同抗血栓療法中の区域麻酔・神経ブロックガイドライン作成ワーキンググループ. 抗血栓療法中の区域麻酔・神経ブロックガイドライン. 2016. https://anesth.or.jp/files/pdf/guideline_kouketsusen.pdf(accessed Mar, 2021)
 

第2章 静脈麻酔薬

P.26 掲載の参考文献
1) White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36.
PubMed
2) Kumar SM, Kothary SP, Zsigmond EK. Lack of cardiovascular stimulation during endotracheal intubation in cardiac surgical patients anesthetized with diazepam-ketamine-pancuronium. Clin Ther 1980;3:43-8.
PubMed
3) Raza SM, Masters RW, Zsigmond EK. Haemodynamic stability with midazolam-ketamine-sufentanil analgesia in cardiac surgical patients. Can J Anaesth 1989;36:617-23.
PubMed
4) Hirota K, Lambert DG. Ketamine:its mechanism(s) of action and unusual clinical uses. Br J Anaesth 1996;77:441-4.
PubMed
5) Hirota K, Lambert DG. Ketamine:new uses for an old drug? Br J Anaesth 2011;107:123-6.
PubMed
6) Kharasch ED, Labroo R. Metabolism of ketamine stereoisomers by human liver microsomes. Anesthesiology 1992;77:1201-7.
PubMed
7) Zielmann S, Kazmaier S, Schnull S, et al. S-(+)-Ketamine and circulation. Anaesthesist 1997;46(suppl 1):S43-6.
 
8) Adams HA. S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia-sedation. Anaesthesist 1997;46:1081-7.
PubMed
9) Pees C, Haas NA, Ewert P, et al. Comparison of analgesic/sedative effect of racemic ketamine and S(+)-ketamine during cardiac catheterization in newborns and children. Pediatr Cardiol 2003;24:424-9.
PubMed
10) Weber F, Wulf H, el Saeidi G. Premedication with nasal s-ketamine and midazolam provides good conditions for induction of anesthesia in preschool children. Can J Anesth 2003;50:470-5.
PubMed
11) Trimmel H, Helbok R, Staudinger T, et al. S(+)-ketamine:current trends in emergency and intensive care medicine. Wien Klin Wochenschr 2018;130:356-66.
PubMed
12) Hirota K, Lambert DG. Ketamine and depression. Br J Anaesth 2018;121:1198-202.
PubMed
13) Malhi GS, Byrow Y, Cassidy F, et al. Ketamine:stimulating antidepressant treatment? BJPsych Open 2016;2:e5-9.
PubMed
14) Hashimoto K. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of(R)-ketamine. Biochem Pharmacol 2020;177:113935.
PubMed
P.30 掲載の参考文献
1) &Herman RJ, Wilkinson GR. Disposition of diazepam in young and elderly subjects after acute and chronic dosing. Br J Clin Pharmacol 1996;42:147-55.
 
2) Lingamchetty TN, Hosseini SA, Saadabadi A. Midazoalm. StatPearls[Internet]. Treasure Island(FL):StatPearls Publishing;2020.
 
3) Sigel E, Ernst M. The benzodiazepine binding sites of GABAA receptors. Trends Pharmacol Sci 2018;39:659-71.
PubMed
4) Masui K. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia J Anesth 2020;34:479-82.
PubMed
5) Freyer N, Knospel F, Damm G, et al. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther 2019;13:1033-47.
 
6) Rogers WK, McDowell TS. Remimazolam, a short-acting GABA(A)receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures. IDrugs 2010;13:929-37.
PubMed
7) Gravielle MC. Activation-induced regulation of GABAA receptors:Is there a link with the molecular basis of benzodiazepine tolerance? Pharmacol Res 2016;109:92-100.
 
8) Yoshikawa H, Hosokawa M, Kashima Y, et al. Remimazolam Tolerance in Long-term Benzodiazepine Users:a case report of 2 cases. A A Pract 2021;15:e01460.
 
P.35 掲載の参考文献
1) Walsh CT. Propofol:milk of amnesia. Cell 2018;175:10-3.
PubMed
2) Rogers KM, Dewar KMS, McCubbin TD, et al. Preliminary experience with ICI 35868 as an i.v. induction agent:comparison with althesin. Br J Anaesth 1980;52:807-10.
 
3) Adam HK, Briggs LP, Bahar M, et al. Pharmacokinetic evaluation of ICI 35868 in man. Single induction doses with different rates of injection. Br J Anaesth 1983;55:97-103.
PubMed
4) Glen JB, Hunter SC. Pharmacology of an emulsion formulation of ICI 35868. Br J Anaesth 1984;56:617-26.
PubMed
5) Kirkpatrick T, Cockshott ID, Douglas EJ, et al. Pharmacokinetics of propofol(diprivan) in elderly patients. Br J Anaesth 1988;60:146-50.
PubMed
6) Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998;88:1170-82.
PubMed
7) Cortinez LI, De la Fuente N, Eleveld DJ, et al. Performance of propofol target-controlled infusion models in the obese:pharmacokinetic and pharmacodynamic analysis. Anesth Analg 2014;119:302-10.
PubMed
8) Eleveld DJ, Colin P, Absalom AR, Struys MMRF. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Br J Anaesth 2018;120:942-59.
 
9) Park JH, Choi SM, Park JH, et al. Population pharmacokinetic analysis of propofol in underweight patients under general anaesthesia. Br J Anaesth 2018;121:559-66.
PubMed
10) Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999;90:1502-16.
PubMed
P.39 掲載の参考文献
1) Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients:the MENDS randomized controlled trial. JAMA 2007;298:2644-53.
 
P.42 掲載の参考文献
1) Marsh B, White M, Morton N, et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991;67:41-8.
PubMed
2) Eger EI II, Shafer SL. Tutorial:context-sensitive decrement times for inhaled anesthetics. Anesth Analg 2005;101:688-96.
 
3) Coetzee JF. Principles of intravenous drug infusion. Anaesth Intensive Care Med 2005;6:141-4.
 
4) Schwilden H, Schuttler J, Stoekel H. Pharmacokinetics as applied to total intravenous anaesthesia. Anaesthesia 1983;38:51-2.
PubMed
5) Wiltshire HR, Kilpatrick GJ, Tilbrook GS, et al. A placebo- and midazolam- controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam(CNS 7056):Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Anesth Analg 2012;115:284-96.
PubMed
6) Schuttler J, Eisenried A, Lerch M, et al. Pharmacokinetics and pharmacodynamics of remimazolam(CNS 7056)after continuous infusion in healthy male volunteers:Part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology 2020;132:636-51.
PubMed
7) Schnider T, Minto C. Context sensitive decrement times of remimazolam. Anesth Analg 2013;117:285.
PubMed
8) 増井健一. Context-sensitive half-time(CSHT)とは何を表すものですか? 内田 整, 編. 臨床の疑問に答える. 静脈麻酔Q & A 99. 東京:羊土社:2015. p.190-1.
 
9) Johnson KB. New horizons in sedative hypnotic drug development:fast, clean, and soft. Anesth Analg 2012;115:220-2.
PubMed
P.46 掲載の参考文献
1) Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94.
PubMed
P.49 掲載の参考文献
1) Tanelian DL, Kosek P, Mody I, et al. The role of the GABAA receptor/chloride channel complex in anesthesia. Anesthesiology 1993;78:757-76.
PubMed
2) Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994;367:607-14.
PubMed
3) Hemmings HC Jr, Akabas MH, Goldstein PA, et al. Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci 2005;26:503-10.
PubMed
4) Perttila J, Lehtonen OP, Salo M, et al. Effects of coronary bypass surgery under highdose fentanyl anaesthesia on granulocyte chemiluminescence. Br J Anaesth 1986;58:1027-30.
PubMed
5) Collins VJ. Intravascular local anesthetics and regional block. Principles of anesthesiology:general and regional anesthesia(vol 1. 3rd ed). Malvern:Lea & Febiger:1993. p.787-808.
 
6) Hirota K, Kushikata T. Central noradrenergic neurones and the mechanism of general anaesthesia. Br J Anaesth 2001;87:811-3.
PubMed
7) Ravi Allada R. An emerging link between general anesthesia and sleep. Proc Natl Acad Sci USA 2008;105:2257-8.
 
8) Franks NP, Zecharia AY. Sleep and general anesthesia. Can J Anesth 2011;58:139-48.
PubMed
9) Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med 2010;363:2638-50.
 
10) Akeju O, Brown EN. Neural oscillations demonstrate that general anesthesia and sedative states are neurophysiologically distinct from sleep. Curr Opin Neurobiol 2017;44:178-85.
PubMed
11) Lee U, Mashour GA. Role of network science in the study of anesthetic state transitions. Anesthesiology 2018;129:1029-44.
 
12) Melonakos ED, Moody OA, Nikolaeva K, et al. Manipulating neural circuits in anesthesia research. Anesthesiology 2020;133:19-30.
 
P.55 掲載の参考文献
1) Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997;78:606-17.
PubMed
2) Hoffmann H, Kettelhack C. Fast-track surgery--conditions and challenges in postsurgical treatment:a review of elements of translational research in enhanced recovery after surgery. Eur Surg Res 2012;49:24-34.
PubMed
3) Pisarska M, Torbicz G, Gajewska N, et al. Compliance with the ERAS protocol and 3-year survival after laparoscopic surgery for non-metastatic colorectal cancer. World J Surg 2019;43:2552-60.
PubMed
4) Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in criticallyill adults:a meta-analysis. JAMA 2008;300:933-44.
 
5) Liu SS, Wu CL. Effect of postoperative analgesia on major postoperative complications:a systematic update of the evidence. Anesth Analg 2007;104:689-702.
PubMed
6) Curatolo M, Sveticic G. Drug combinations in pain treatment:a review of the published evidence and a method for finding the optimal combination. Best Pract Res Clin Anaesthesiol 2002;16:507-19.
 

第3章 オピオイドとオピオイドアンタゴニスト

P.60 掲載の参考文献
1) Goldstein A, Lowney LI, Pal BK. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fraction of mouse brain. PNAS 1971;68:1742-7.
PubMed
2) Pert CB, Snyder SH. Opiate receptor:demonstration in nervous tissue. Science 1973;179:1011-4.
PubMed
3) Simon EJ, Hiller JM, Edelman I. Stereospecific binding of the potent narcotic analgesic [3H]etorphine to rat-brain homogenate. PNAS 1973;70:1947-9.
PubMed
4) Terenius L. Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol Toxicol 1973;33:377-84.
PubMed
5) Manglik A, Lin H, Aryal DK, et al. Structure-based discovery of opioid analgesics with reduced side effects. Nature 2016;537:195-90.
 
P.63 掲載の参考文献
1) Cavillo O, Henry JL, Neuman RS. Effects of morphine and naloxone on dorsal horn neurons in the cat. Can J Physiol Pharmacol 1974;52:1207-11.
 
2) Kitahata LM, Kosaka Y, Taub A, et al. Lamina-speciific suppression of dorsal-horn unit activity by morphine sulfate. Anesthesiology 1974;41:38-48.
 
3) Lebars D, Menetrey D, Besson JM. Effects of morphine upon the lamina V type cells activities in the dorsal horn of the decerebrate cat. Brain Res 1976;113:293-310.
PubMed
4) Pert CB, Kuhar MJ, Snyder SH. Opiate receptor:autoradiographic localization in rat brain. PNAS 1976;73:3729-33.
PubMed
5) Yaksh TL, Rudy TA. Direct spinal action of narcotics. Science 1976;192:1357-8.
PubMed
P.66 掲載の参考文献
1) Lee LA, Caplan RA, Stephens LS, et al. Postoperative opioid-induced respiratory depression A closed claims analysis. Anesthesiology 2015;122:659-65.
PubMed
2) Dehan A, van Dam CJ, Niesters M, et al. Benefit and risk evaluation of biased m-receptor agonist oliceridine versus morphine. Anesthesiology 2020;133:559-68.
 
3) Manglik A, Lin H, Aryal DK, et al. Strucure-based discovery of opioid analgesics with reduced side effects. Nature 2016;537:185-90.
 
P.69 掲載の参考文献
1) Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008;358:2322-43.
 
2) Katakami N, Harada T, Murata T, et al. Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer. J Clin Oncol 2017;35:3859-66.
 
3) Candy B, Jones L, Vickerstaff V, et al. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev 2018;6:CD006332.
PubMed

第4章 痛み, 鎮痛法

P.73 掲載の参考文献
1) Beecher HK. Pain and some factors that modify it. Anesthesiology 1951;12:633-41.
PubMed
2) Berde C, McGrath P. Pain measurement and Beecher's challenge:50 years later. Anesthesiology 2009;111:473-4.
 
P.75 掲載の参考文献
1) Beecher HK. Pain and some factors that modify it. Anesthesiology 1951;12:633-41.
PubMed
2) Medical milestones. Celebrating key advances since 1840. http://www.bmj.com/content/bmj/suppl/2007/01/18/334.suppl_1.DC2/milestones.pdf(accessed July, 2021)
 
P.77 掲載の参考文献
1) Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983;306:686-8.
PubMed
2) Richmond CE, Bromley LM, Woolf CJ. Preoperative morphine pre-empts postoperative pain. Lancet 1993;342:73-5.
PubMed
3) Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-5.
PubMed
4) Cook AJ, Woolf CJ, Wall PD, et al. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 1987;325:151-3.
PubMed
5) Woolf CJ, Chong MS. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analgn 1993:77:362-79.
PubMed
P.80 掲載の参考文献
1) Tverskoy M, Cozacov C, Ayache M, et al. Postoperative pain after inguinal herniorrhaphy with different types of anesthesia. Anesth Analg 1990;70:29-35.
PubMed
2) Melzack R, Wall PD. Pain mechanisms:a new theory. Science 1965;150:971-9.
PubMed

第5章 吸入麻酔薬

P.84 掲載の参考文献
1) Warren JC. Inhalation of ethereal vapor for the prevention of pain in surgical operation. Boston Med Surg J 1846;35:375-9.
 
P.87 掲載の参考文献
1) Merkel G, Eger EI II. A comparative study of halothane and halopropane anesthesia including method for determining equipotency. Anesthesiology 1963;24:346-57.
 
2) Saidman LJ, Eger EI II. Effect of nitrous oxide and of narcotic premedication on the alveolar concentration of halothane required for anesthesia. Anesthesiology 1964;25:302-6.
 
P.90 掲載の参考文献
1) Eger IE. Isoflurane:a review. Anesthesiology 1981;55:559-76.
 
2) Saidman LJ, Eger EI II, Munson ES, et al. Minimum alveolar concentration of methoxyflurane, halothane, ether and cyclopropane in man:correlation with theories of anesthesia. Anesthesiology 1967;28:994-1002.
 
3) Waud DR. On biological assays involving quantal responses. J Pharmacol Exp Ther 1972;183:577-607.
PubMed
4) Terrell CR. The invention and development of enflurane, isoflurane, sevoflurane, and desflurane. Anesthesiology 2008;108:531-3.
 
P.94 掲載の参考文献
1) Wallin RF, Napoli MD. Sevoflurane(fluoromethyl-1,1,1,3,3,3,-hexafluro-2-propyl ether):a new inhalational anesthetic agent(abstract). Fed Proc 1971;30:442.
 

第6章 局所麻酔薬

P.99 掲載の参考文献
1) Narahashi T, Frazier DT, Yamada M. The site of action and active form of local anesthetics. I. Theory and pH experiments with tertiary compounds. J Pharmacol Exp Ther 1970;171:32-44.
 
2) Strichartz GR. The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J Gen Physiol 1973;62:37-57.
PubMed
P.103 掲載の参考文献
1) Strichartz GR. The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J Gen Physiol 1973;62:37-57.
PubMed
2) Hille B. Mecahnsms of blockade. Ion channels of excitable membrane(3rd ed). Massachusetts:Sinauer Associates;2001. p.503-38.
 
3) 森 隆. 麻酔とイオンチャネル・受容体:局所麻酔薬, 全身麻酔薬の作用機序. 阪市医誌2020;69:1-7.
 
4) Tomin J, zivanov-curlis J, Popovic D, et al. Differences in local anesthetic effects of optically active isomers of local anesthetic compounds. Biotechnol Biotechnol Equip 2006;20:9-14.
 

第7章 筋弛緩薬と筋弛緩薬モニタリング

P.108 掲載の参考文献
1) Mushin WW, Wien R, Mason DFJ, et al. Curare-like actions of tri-(diethylaminoethoxy)-benzen triethyliodide. Lancet 1949;1:21.
 
2) Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery:based on a study of 599,548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954;140:2-35.
PubMed
3) Thesleff S. Succinylcholine iodide:studies on its pharmacological properties and clinical use. Acta Physiol Scand Suppl 1952;27:1-36.
PubMed
4) Christie TH, Churchill-Davidson HC. The St. Thomas's hospital nerve stimulator in the diagnosis of prolonged apnoea. Lancet 1958;1:776.
 
5) Ali HH, Utting JE, Gray C. Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth 1970;42:967-78.
PubMed
6) Ali HH, Utting JE, Nightingale DA, et al. Quantitative assessment of residual curarization in humans. Br J Anaesth 1970;42:802-3.
PubMed
7) Harver AM, Masland RL. A method for the study of neuromuscular transmission in human subjects. Bull Johns Hopkins Hosp 1941;68:81-93.
 
8) 日本麻酔科学会. 安全な麻酔のためのモニター指針. 2019. https://anesth.or.jp/files/pdf/monitor3_20190509.pdf(accessed Feb, 2021)
 
P.112 掲載の参考文献
1) Griffith HR, Johnson JG. The use of curare in general anesthesia. Anesthesiology 1942;3:418-20.
 
2) Hershey WN, Wahrenbrock EA, De Jong RH. Residual curarization. Anesthesiology 1965;26:834.
PubMed
3) Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. I. Br J Anaesth 1971;43:473-7.
 
4) Viby-Mogensen J, Jorgensen BC, Ording H. Residual curarization in the recovery room. Anesthesiology 1979;50:539-41.
PubMed
5) Carvalho H, Verdonck M, Cools W, et al. Forty years of neuromuscular monitoring and postoperative residual curarisation:a meta-analysis and evaluation of confidence in network meta-analysis. Br J Anaesth 2020;125:466-82.
PubMed
6) Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997;86:765-71.
PubMed
7) Plaud B, Debaene B, Donati F, et al. Residual paralysis after emergence from anesthesia. Anesthesiology 2010;112:1013-22.
PubMed

第8章 小児麻酔

P.118 掲載の参考文献
1) Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003;23:876-82.
PubMed
2) Sun LS, Li G, Miller TL, et al. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA 2016;315:2312-20.
PubMed
3) Warner DO, Zaccariello MJ, Katusic SK, et al. Neuropsychological and behavioral outcomes after exposure of young children to procedures requiring general anesthesia:the Mayo Anesthesia Safety in Kids(MASK)study. Anesthesiology 2018;129:89-105.
PubMed
4) McCann ME, de Graaff JC, Dorris L, et al. Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy(GAS):an international, multicentre, randomised, controlled equivalence trial. Lancet 2019;393:664-77.
 
P.121 掲載の参考文献
1) Eckenhoff JE. Some anatomic considerations of the infant larynx influencing endotracheal anesthesia. Anesthesiology 1951;12:401-10.
PubMed
2) Bayeux R. Tubage du larynx dans le croup. Presse Med 1897;20:1-4.
 
3) Dalal PG, Murray D, Messner AH, et al. Pediatric laryngeal dimensions:an age-based analysis. Anesth Analg 2009;108:1475-9.
PubMed
4) Motoyama EK. The shape of the pediatric larynx:cylindrical or funnel shaped? Anesth Analg 2009;108:1379-81.
PubMed
5) Joshi VV, Mandavia SG, Stern L, et al. Acute lesions induced by endotracheal intubation:occurrence in the upper respiratory tract of newborn infants with respiratory distress syndrome. Am J Dis Child 1972;124:646-9.
PubMed
6) Weiss M, Dullenkopf A, Fischer JE, et al. Prospective randomized controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small children. Br J Anaesth 2009;103:867-73.
PubMed

第9章 産科麻酔

P.126 掲載の参考文献
1) Apgar V, Holaday DA, James LS, et al. Evaluation of the newborn infant;second report. J Am Med Assoc 1958;168:1985-8.
PubMed
2) Butterfield J, Covey MJ. Practical epigram of the Apgar score. JAMA 1962;181:353.
 
3) Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med 2001;344:467-71.
PubMed
P.129 掲載の参考文献
1) Amiel-Tison C, Barrier G, Shnider SM, et al. A new neurologic and adaptive capacity scoring system for evaluating obstetric medications in full-term newborns. Anesthesiology 1982;56:340-50.
PubMed

第10章 脳神経外科麻酔・脳保護

P.134 掲載の参考文献
1) Kennedy C, Sokoloff L. An adaptation of the nitrous oxide method to the study of the cerebral circulation in children;normal values for cerebral blood flow and cerebral metabolic rate in childhood. J Clin Invest 1957;36:1130-7.
 
2) Cohen PJ, Alexander SC, Smith TC, et al. Effects of hypoxia and normocarbia on cerebral blood flow and metabolism in conscious man. J Appl Physiol 1967;23:183-9.
 
3) Wells BA, Keats AS, Cooley DA. Increased tolerance to cerebral ischemia produced by general anesthesia during temporary carotid occlusion. Surgery 1963;54:216-23.
PubMed
4) Michenfelder JD, Theye RA. The effects of anesthesia and hypothermia on canine cerebral ATP and lactate during anoxia produced by decapitation. Anesthesiology 1970;33:430-9.
PubMed
5) Michenfelder JD. The anesthetized brain. In:Michenfelder JD, editor. Anesthesia and the brain. New York:Churchill Livingstone;1988. p.35-48.
 
6) Smith AL, Hoff JT, Nielsen SL, et al. Barbiturate protection in acute focal cerebral ischemia. Stroke 1974;5:1-7.
PubMed
7) Bleyaert AL, Nemoto EM, Safar P, et al. Thiopental amelioration of brain damage after global ischemia in monkeys. Anesthesiology 1978;49:390-8.
PubMed
8) BRCTS group. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986;314:397-442.
 
P.137 掲載の参考文献
1) Ito U, Spatz M, Walker JT Jr., et al. Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations. Acta Neuropathol 1975;32:209-23.
PubMed
2) Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982;239:57-69.
 
3) Olney JW. Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol 1969;28:455-78.
PubMed
4) Monaghan DT, Holets VR, Toy DW, et al. Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature 1983;306:176-9.
PubMed
5) 松本美志也, 石田和慶. 虚血性神経細胞死の特徴. 牛島一男, 編. 虚血性中枢神経障害の基礎と臨床. 東京:真興交易医書出版部;2016. p.12-36.
 

第11章 心臓麻酔, 心保護, 心合併症

P.142 掲載の参考文献
1) Grant MC, Isada T, Ruzankin P, et al. Opioid-sparing cardiac anesthesia:secondary analysis of an enhanced program for cardiac surgery. Anesth Analg 2020;131:1852-61.
PubMed
P.145 掲載の参考文献
1) Heyndrickx GR, Baig H, Nellers P, et al. Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 1978;234:H653.
PubMed
2) Ellis SG, Henschke CI, Sandor T, et al. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. Am J Cardiol 1983;1:1047-55.
 
3) Puri PS. Contractile and biochemical effects of coronary reperfusion after extended periods of coronary occlusion. Am J Cardiol 1975;36:244.
PubMed
4) Weiner JM, Apstein CS, Arthur JH, et al. Persistence of myocardial injury following brief periods of coronary occlusion. Cardiovasc Res 1976;10:678-86.
 
5) Wood JM, Hanley HG, Entman ML, et al. Biochemical and morphological correlates of acute experimental myocardial ischemia in the dog. IV. Energy mechanisms during very early ischemia. Circ Res 1979;44:52-61.
PubMed
6) Hess ML, Barnhart GR, Crute S, et al. Mechanical and biochemical effects of transient myocardial ischemia. J Surg Res 1979;26:175-84.
PubMed
7) DeBoer FWV, Ingwall JS, Kloner RA, et al. Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis. Proc Nat Acad Sci 1970;77:5471-5.
 
8) Jennings RB. Early phase of myocardial ischemic injury and infarction. Am J Cardiol 1969;24:753-65.
PubMed
9) Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography. Circulation 1982;65:1497-503.
PubMed
10) Warltier DC, al-Wathiqui MH, Kampine JP, et al. Recovery of contractile function of stunned myocardium in chronically instrumented dogs in enhanced by halothane or isoflurane. Anesthesiology 1988;69:552-65.
 
P.149 掲載の参考文献
1) Slogoff S, Keats AS. Myocardial ischemic revisited. Anesthesiology 2006;105:214-6.
PubMed
P.152 掲載の参考文献
1) Murry CE, Jennings BS, Reimer KA. Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
 
2) Lia S, Hafeezc A, Noorulla F, et al. Preconditioning in neuroprotection:from hypoxia to ischemia. Prog Neurobiol 2017;157:79-91.
 
3) Suyavaran A, Thirunavukkarasu C. Preconditioning methods in the management of hepatic ischemia reperfusion- induced injury:update on molecular and future perspectives. Hepatol Res 2017;47:31-48.
PubMed
4) Zhao L, Hu C, Zhang P, et al. Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury. J Cell Mol Med 2019;23:720-30.
PubMed
5) Donato M, Evelson P, Gelpi RJ. Protecting the heart from ischemia/reperfusion injury:an update on remote ischemic preconditioning and postconditioning. Curr Opin Cardiol 2017;32:784-90.
PubMed
6) Pagel PS, Crystal GJ. The discovery of myocardial preconditioning using volatile anesthetics:a history and contemporary clinical perspective. J Cardiothorac Vasc Anesth 2018;32:1112-34.
PubMed
P.156 掲載の参考文献
1) Smilowtz NR, Berger JS. Perioperative cardiovascular risk assessment and management for noncardiac surgery. JAMA 2020;324:279-90.
 
P.159 掲載の参考文献
1) Murry CE, Jennings BS, Reimer KA. Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
 
2) Warltier DC, al-Wathiqui MH, Kampine JP, et al. Recovery of contractile function of stunned myocardium in chronically instrumented dogs in enhanced by halothane or isoflurane. Anesthesiology 1988;69:552-65.
 
3) Stowe DF, Kevin LG. Cardiac preconditioning by volatile anesthetic agents:a defining role for altered mitochondrial bioenergetics. Antioxid Redox Signal 2004;6:439-48.
PubMed
4) Belhomme D, Peynet J, Louzy M, et al. Evidence of preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999;100(suppl II):340-4.
 
5) De Hert SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002;97:42-9.
PubMed
6) Conzen PF, Fischer S, Detter C, et al. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003;99:826-33.
PubMed
7) De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004;101:9-20.
PubMed
8) Zaugg M, Wang L, Zhang L, et al. Choice of anesthetic combination determines Ca2+ leak after ischemia-reperfusion injury in the working rat heart:favorable versus adverse combinations. Anesthesiology 2012;116:648-57.
PubMed
9) Zhou C, Liu J. A novel intravenous general anesthetic--emulsified isoflurane:from bench to bedside. Front Med 2012;6:381-7.
 

第12章 モニタリング

P.164 掲載の参考文献
1) Cournand A, Rilet RL, Breed ES, et al. Measurement of cardiac output in man using the technique of catheterization of the right auricle or ventricule. J Clin Invest 1945;24:106-16.
 
2) Ganz W, Donoso R, Marcus HS, et al. A new technique for measurement od cardiac output by thermodilution in man. Am J Cardiol 1971;27:392-6.
 
P.168 掲載の参考文献
1) Plomley F. On operations on the eye. Lancet 1847;1:134-5.
 
2) Snow J. On narcotism by the inhalation of vapors:the first seven parts. London:Wilson & Ogilvy;1848.
 
3) Eger El II, Saidman LJ, Brandstater B. Minimum aveolar anesthetic concentration:a standard of anesthetic potency. Anestesiology 1965;26:756-63.
 
4) Eger El II, Brandstater B, Saidman LJ, et al. Equipotent alveolar concentrations of methoxyflurane, halothane, diethyl ether, fluroxene, cyclopropane, xenon, and nitrous oxide in the dog. Anesthesiolocy 1965;26:771-7.
 
5) Munson ES, Saidman LJ, Eger El II. Effect of nitrous oxide and morphine on the minimum anesthetic concentrations of fluroxene. Anesthesiology 1965;26:134-9.
 
6) Saidman LJ, Eger El II, Munson ES, et al. Minimum alveolar concentrations of methoxyflurane, halothane, ether, and cyclopropane in man. Anesthesiology 1967;28:994-1002.
 
7) Stoelting RK, Longnecker DE, Eger EI II. Minimum alveolar concentrations in man on awakening from methoxyflurane, ha1othane, ether and fluroxene anesthesia. MAC awake. Anesthesiology 1970;33:5-9.
 
8) Guedel AE. lnhatlation anesthesia:a fundamental guide. New York;Macmillan:1937.
 
9) Gillespie NA. The signs and reflex reactions of the stages of anesthesia. Anesth Analg (Cleve)1945;22:275.
 
10) Berger H. Ueber das elektroenkephalogramm des menschen. Achte mitteilung. Arch Psychiatr Nervenkr 1934;101:452-69.
 
11) Berger H. Ueber das elektroenkephalogram des menschen. Dritte mitteilung. Arch Psychiatr Nervenkr 1931;94:16-60.
 
12) Martin JT, Faulconer A Jr, Bickford RG. Electroencephalography in anesthesiology. Anesthesiology 1959;20:359-76.
 
13) Dawson GE. A summation technique for the detection of small evoked potentials. Electroencephalogr Clin Neurophysiol 1954;6:65-84.
 
14) Schneider G, Jordan D, Schwarz G, et al. Monitoring depth of anesthesia utilizing a combination of electroencephalographic and standard measures. Anesthesiology 2014;120:819-28.
PubMed
P.172 掲載の参考文献
1) Frazin L, Talano JV, Stephanides L, et al. Esophageal echocardiography. Circulation 1976;54:102-8.
PubMed
2) Matsuzaki M, Matsuda Y, Ikee Y, et al. Esophageal echocardiographic left ventricular anterolateral wall motion in normal subjects and patients with coronary artery disease. Circulation 1981;63:1085-92.
PubMed
3) Matsumoto M, Oka Y, Lin YT, et al. Transesophageal echocardiography;for assessing ventricular performance. N Y State J Med 1979;79:19-21.
 
P.175 掲載の参考文献
1) 特許情報プラットフォーム. 特開昭50-128387 光学式血液測定装置. https://www.j-platpat.inpit.go.jp/gazette_work3/domestic/A/350128000/350128300/350128380/350128387/EC903297CCBE833ABA9F414DB5C9721FAAC22856B0A54B3084BD086A2B318B98/JPA%201975128387-000000.pdf(accessed Apr, 2021)
 
2) コニカミノルタ. パルスオキシメータの歴史. https://www.konicaminolta.jp/healthcare/knowledge/details/history.html(accessed Apr, 2021)
 
P.179 掲載の参考文献
1) Snow J. On the inhalation of the vapors of ether in surgical operations. Containing a description of the various stages of etherization and a statement of the results of nearly eighty operations in which ether has been employed at St. George's and University College hospitals. London:John Churchill;1847. p.1-15.
 
2) Snow J. On chloroform and other anesthetics. London:John Churchill;1858. i-xliv.
 
3) Guedel AE. Inhalational anesthesia:a fundamental guide. New York:Macmillan;1937.
 
4) Stanski DR. Monitoring depth of anesthesia. Anesthesia(3rd ed). In:Miller RD, editor. New York:Churchill Livingston;1990. 1127-59.
 
5) Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. J Clin Monit 1994;10:392-404.
PubMed
6) 川西秀明, 林 浩伸. 全身麻酔科で神経機能を確認するためのモニタリング機器. 臨床麻酔2019;43:1611-21.
 
7) 水野谷和之, 森本裕二. 脳波モニタと筋弛緩モニタ. 医機学2016;86:31-6.
 

第13章 輸血

P.184 掲載の参考文献
1) 丸藤 哲, 亀上 隆, 澤村 淳, ほか. 外傷後にみられる血液凝固線溶系の変化:新しい考え方と治療方法. 日救急医会誌 2006;17:629-44.
 
2) Hiippala S. Replacement of massive blood loss. Vox Sang 1998;74:399-407.
PubMed
P.187 掲載の参考文献
1) Yazer MH, Sperry JL, Cap AP, et al. If not now, when? The value of the MTP in managing massive bleeding. Blood Transfus 2020;18:415-8.
PubMed
2) Gonzalez E, Moore EE, Moore HB, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg 2016;263:1051-9.
PubMed

第14章 体温・悪性高熱症

P.191 掲載の参考文献
1) Denborough MA, Lovell RRH. Anaesthetic deaths in a family. Lancet 1960;2:45.
 
2) 奥村福一郎, 高折益彦. 全身麻酔中に発生せる突発性高体温症について. 麻酔1968;17:792-6.
 
3) 盛生倫夫, 仁王菊男, 大谷美奈子, ほか. わが国における麻酔時悪性過高熱の集計. 麻酔と蘇生1974;10:73-91.
 
4) 盛生倫夫, 菊地博達, 弓削孟文, ほか. 悪性高熱症診断基準の見直し. 麻酔と蘇生(別冊)悪性高熱研究の進歩XI 1988;24:104-10.
 
5) Harrison GG. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth 1975;47:62-5.
PubMed
6) Endo M, Tanaka M, Ogawa Y. Calcium induced release of calcium from the sarcoplasmic reticulum of skinned skeletal muscle fibres. Nature 1970;228:34-6.
PubMed
7) Endo M, Yagi S, Ishizuka T, et al. Changes in the Ca-induced Ca release mechanism in the sarcoplasmic reticulum of the muscle from a patient with malignant hyperthermia. Biomedical Res 1983;4:83-92.
 
8) Kalow W, Britt BA, Terreau ME, et al. Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet 1970;2:895-8.
PubMed
9) Ellis FR, Harriman DG, Keaney NP, et al. Halothane-induced muscle contracture as a cause of hyperpyrexia. Br J Anaesth 1971;43:721-2.
PubMed
10) Larach MG. Standardization of the caffeine halothane muscle contracture test. North American malignant hyperthermia group. Anesth Analg 1989;69:511-5.
PubMed
11) Mickelson JR, Gallant EM, Litterer LA, et al. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 1988;263:9310-5.
PubMed
12) McCarthy TV, Healy JMS, Heffron JJA, et al. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 1990;343:562-4.
 
P.194 掲載の参考文献
1) Sessler DI. The thermoregulation story. Anesthesiology 2013;118:181-6.
PubMed
2) Matsukawa T, Kurz A, Sessler DI, et al. Propofol linearly reduces the vasoconstriction and shivering thresholds. Anesthesiology 1995;82:1169-80.
PubMed
3) Kurz A, Ikeda T, Sessler DI, et al. Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold. Anesthesiology 1997;86:1046-54.
PubMed
4) Kurz A, Go JC, Sessler DI, et al. Alfentanil slightly increases the sweating threshold and markedly reduces the vasoconstriction and shivering thresholds. Anesthesiology 1995;83:293-9.
PubMed
5) Xiong J, Kurz A, Sessler DI, et al. Isoflurane produces marked and nonlinear decreases in the vasoconstriction and shivering thresholds. Anesthesiology 1996;85:240-5.
PubMed
6) Sessler DI, McGuire J, Hynson J, et al. Thermoregulatory vasoconstriction during isoflurane anesthesia minimally decreases cutaneous heat loss. Anesthesiology 1992;76:670-5.
PubMed
7) Kurz A, Xiong J, Sessler DI, et al. Desflurane reduces the gain of thermoregulatory arteriovenous shunt vasoconstriction in humans. Anesthesiology 1995;83:1212-9.
PubMed
8) Matsukawa T, Sessler DI, Sessler AM, et al. Heat flow and distribution during induction of general anesthesia. Anesthesiology 1995;82:662-73.
PubMed
9) Matsukawa T, Sessler DI, Christensen R, et al. Heat flow and distribution during epidural anesthesia. Anesthesiology 1995;83:961-7.
PubMed
10) Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of wound infection and temperature group. N Engl J Med 1996;334:1209-15.
 
11) Schmied H, Kurz A, Sessler DI, et al. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996;347:289-92.
PubMed
P.197 掲載の参考文献
1) Sessler DI. Perianesthetic thermoregulation and heat balance in humans. FASEB J 1993;7:638-44.
PubMed
2) Ozaki M, Kurz A, Sessler DI, et al. Thermoregulatory thresholds during epidural and spinal anesthesia. Anesthesiology 1994;81:282-8.
PubMed
3) Kurz A, Sessler DI, Schroeder M, et al. Thermoregulatory response thresholds during spinal anesthesia. Anesth Analg 1993;77:721-6.
PubMed
4) Joris J, Ozaki M, Sessler DI, et al. Epidural anesthesia impairs both central and peripheral thermoregulatory control during general anesthesia. Anesthesiology 1994;80:268-77.
PubMed
5) Matsukawa T, Sessler DI, Christensen R, et al. Heat flow and distribution during epidural anesthesia. Anesthesiology 1995;83:961-7.
PubMed
6) Szmuk P, Ezri T, Sessler DI, et al. Spinal anesthesia speeds active postoperative rewarming. Anesthesiology 1997;87:1050-4.
PubMed
7) Camus Y, Delva E, Sessler DI, et al. Pre-induction skin-surface warming minimizes intraoperative core hypothermia. J Clin Anesth 1995;7:384-8.
PubMed
8) Leslie K, Sessler DI. Perioperative hypothermia in the high-risk surgical patient. Best Pract Res Clin Anaesthesiol 2003;17:485-98.
PubMed
9) Sessler DI, Schroeder M, Merrifield B, et al. Optimal duration and temperature of prewarming. Anesthesiology 1995;82:674-81.
PubMed
10) Mokhtarani M, Mahgoub AN, Morioka N, et al. Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg 2001;93:1233-9.
PubMed
11) Doufas AG, Lin CM, Suleman MI, et al. Dexmedetomidine and meperidine additively reduce the shivering threshold in humans. Stroke 2003;34:1218-23.
PubMed
12) Alfonsi P, Passard A, Gaude-Joindreau V, et al. Nefopam and alfentanil additively reduce the shivering threshold in humans whereas nefopam and clonidine do not. Anesthesiology 2009;111:102-9.
 

第15章 気道管理

P.202 掲載の参考文献
1)) Brain AJ. The development of the laryngeal mask--a brief history of the invention, early clinical studies and experimental work from which the laryngeal mask evolved. Eur J Anaesthesiol 1991;4:5-17.
 
2)) 浅井 隆. これでわかった!図説ラリンジアルマスク. 東京:克誠堂出版;2009年. p.1-186.
 
3)) Asai T, Morris S. The laryngeal mask airway:its features, effects and role. Can J Anaesth 1994;41:930-60.
PubMed
4)) Practice guidelines for management of the difficult airway. An updated report by the American Society of Anesthesiologists Task Force on management of the difficult airway. Anesthesiology 2013;118:251-70.
PubMed
5)) Japanese Society of Anesthesiologists. JSA airway management guideline 2014:to improve the safety of induction of anesthesia. J Anesth 2014;28:482-93.
PubMed
P.205 掲載の参考文献
1)) Macintosh RR. A new laryngoscope. Lancet 1943;1:205.
 
2)) Garcia M. Observation of the human voice. Proc Roy Soc Lond 1856;7:399-410.
 
3)) Kirstein A. Direct laryngoscopy. Lancet 1895;1:1132.
 
4)) Jackson C. The technique of insertion of intratracheal insufflation tubes. Surg Gynecol Obstet 1913;17:507-9.
 
5)) Janeway HH. Intratracheal anesthesia from the standpoint of the nose, throat and oral surgeon with a description of a new instrument for catheterizing the trachea. Laryngoscope 1913;23:1082-90.
 
6)) Magill IW. The provision for expiration in endotracheal insufflation anaesthesia. Lancet 1923;2:68-9.
 
7)) Macintosh RR. Laryngoscope blades. Lancet 1944;1:485.
 
8)) Asai T, Matsumoto S, Fujise K, et al. Comparison of two Macintosh laryngoscope blades in 300 patients. Br J Anaesth 2003;90:457-60.
PubMed
P.210 掲載の参考文献
1) Sellick BA. Cricoid pressure to control regurgitation of gastric contents during induction of anaesthesia. Lancet 1961;2:404-5.
PubMed
2) Tunstall ME. Anaesthesia for obstetric operations. Clin Obstetr Gynaecol 1980;7:665-94.
 
3) Caplan RA, Posner KL, Ward RJ, et al. Adverse respiratory events in anesthesia:a closed claim analysis. Anesthesiology 1990;72:828-33.
PubMed
4) Cook TM, Woodall N, Frerk C. Major complications of airway management in the UK:results of the 4th National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1 Anaesthesia. Br J Anaesth 2011;106:617-31.
 
5) Mushambi MC, Kinsella SM, Popat M, et al. Obstetric Anaesthetists' Association;Difficult Airway Society. Obstetric Anaesthetists' Association and Difficult Airway Society guidelines for the management of difficult and failed tracheal intubation in obstetrics. Anaesthesia 2015;70:1286-306.
 

第16章 一酸化窒素

P.213 掲載の参考文献
1) Manktelow C, Bigatello M, Hess D, et al. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1997;87:297-307.
 
2) Cuthbertson BH, Dellinger P, Dyar OJ, et al. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs:American-European Consensus Conference on ALI/ARDS. Intensive Care Med 1997;23:1212-8.
PubMed
3) Cosby K, Partovi KS, Crawford JH, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003;9:1498-505.
PubMed
4) Ruan SY, Huang TM, Wu HY, et al. Inhaled nitric oxide therapy and risk of renal dysfunction:a systematic review and meta-analysis of randomized trials. Crit Care 2015;19:137-46.
 
P.215 掲載の参考文献
1) Frostell C, Fratacci MD, Wain JC, et al. Inhaled nitric oxide:a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-47.
PubMed
2) Bronicki RA, Fortenberry J, Schreiber M, et al. Multicenter randomized controlled trial of inhaled nitric oxide for pediatric acute respiratory distress syndrome. J Pediatr 2015;166:365-9.
PubMed
3) Bhalla AK, Yehya N, Mack WJ, et al. The association between inhaled nitric oxide treatment and ICU mortality and 28-day ventilator-free days in pediatric acute respiratory distress syndrome. Crit Care Med 2018;46:1803-10.
PubMed

第17章 ICU 呼吸管理

P.220 掲載の参考文献
1) Mapleson WW. The elimination of rebreathing in various semi-closed anaesthetic systems. Br J Anaesth 1954;26:323-32.
PubMed
2) Brockwell RC, Andrews JJ. In:Miller RD, editor. 吸入麻酔薬の供給システム. 武田純三, 監訳. ミラー麻酔科学(6th ed). 東京:メディカル・サイエンス・インターナショナル;2007. p.232-33.
 
3) Mapleson WW. Editorial I:Fifty years after--reflections on 'The elimination of rebreathing in various semi-closed anaesthetic systems'. Br J Anaesth 2004;93:319-21.
PubMed
4) Kain ML, Nunn JF. Fresh gas original investigations of the magill circuit. Anesthesiology 1968;29:964-74.
 
P.223 掲載の参考文献
1) West JB, Dollery CT, Naimark A. Distribution of blood flow in isolated lung;relation to vascular and alveolar pressures. J Appl Physiol 1964;19:713-24.
 
2) Wilson WC, Benumof JL. In:Miller RD, editor. 呼吸生理学と麻酔中の呼吸機能. 武田純三, 監訳. ミラー麻酔科学(6th ed). 東京:メディカル・サイエンス・インターナショナル;2007. p.533-34.
 
3) Hopper T, Nickells J, Payne S, et al. 生理学. 長坂安子, 監訳. グラフィック麻酔学. 東京:メディカル・サイエンス・インターナショナル;2018. p.57.
 
P.225 掲載の参考文献
1) Froese AB, Bryan AC. Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology 1974;41:242-55.
PubMed
2) Wilson WC, Benumof JL. In:Miller RD, editor. 呼吸生理学と麻酔中の呼吸機能. 武田純三, 監訳. ミラー麻酔科学(6th ed). 東京:メディカル・サイエンス・インターナショナル;2007. p.556.
 
P.229 掲載の参考文献
1) Qvist J, Pontoppidan H, Wilson RS. Hemodynamic responses to mechanical ventilation with PEEP:the effect of hypervolemia. Anesthesiology 1975;42:45-55.
PubMed

第18章 術後管理・合併症

P.234 掲載の参考文献
1) Cozowicz C, Memtsoudis SG. Perioperative management of the patient with obstructive sleep apnea:a narrative review. Anesth Analg 2021;132:1231-43.
PubMed
2) Soffin EM, Lee BH, Kumar KK, et al. The prescription opioid crisis:role of the anaesthesiologist in reducing opioid use and misuse. Br J Anaesth 2019;122;e198-208.
PubMed
P.237 掲載の参考文献
1) Gan TJ, Belani KG, Bergese S, et al. Fourth Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2020;131:411-48.
PubMed
2) Egan TD. Are opioids indispensable for general anaesthesia? Br J Anaesth 2019;122:e127-35.
PubMed

書評

最近チェックした商品履歴

Loading...